Advertisement

60 Results

for author "Marco Montillo"

Type a term to search within all articles in this journal: e.g., stem cell
Citation
Citation-specific search information
e.g., 2009
e.g., 20
e.g., 3
e.g., 29
e.g., 10.9999/123XYZ456
Authors, Keywords
Search for specific authors and/or words and phrases.
e.g., Smith, JS
e.g., Smith, JS
Type any phrase that appears in the article title
Type any phrase that appears within article title or abstract
Type any phrase that appears within article body, title or abstract
e.g., Smith, JS
Book publisher name
Limit Results
Limit search results by date
Date of Publication
e.g., 2017-06-27
e.g., 2017-06-27
Format Results
  • Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLL
    Paul M. Barr, Jennifer R. Brown, Peter Hillmen, Susan O'Brien, Jacqueline C. Barrientos, Nishitha M. Reddy, Steven Coutre, Stephen P. Mulligan, Ulrich Jaeger, Richard R. Furman, Florence Cymbalista, Marco Montillo, Claire Dearden, Tadeusz Robak, Carol Moreno, John M. Pagel, Jan A. Burger, Samuel Suzuki, Juthamas Sukbuntherng, George Cole, Danelle F. James, John C. Byrd
  • Analysis of the Early Clonal Dynamics in Ibrutinib-Treated Chronic Lymphocytic Leukemia
    Valeria Spina, Fary Diop, Alessio Bruscaggin, Lorenzo De Paoli, Chiara Favini, Anastasios Stathis, Bernhard Gerber, Lydia Scarfò, Antonella Zucchetto, Clara Deambrogi, Daniela Clerici, Martina di Trani, Andrea Rinaldi, Pietro Bulian, Carmelo Carlo Stella, Francesco Zaja, Paolo Ghia, Michael Gregor, Jakob Passweg, Luca Laurenti, Emanuele Zucca, Franco Cavalli, Francesco Bertoni, Valter Gattei, Marco Montillo, Alessandra Tedeschi, Georg Stüssi, Gianluca Gaidano, Davide Rossi
  • Reappraising Immunoglobulin Repertoire Restrictions in Chronic Lymphocytic Leukemia: Focus on Major Stereotyped Subsets and Closely Related Satellites
    Andreas Agathangelidis, Anastasia Hadzidimitriou, Eva Minga, Lesley-Ann Sutton, Eleftheria Polychronidou, Tait D. Shanafelt, Zadie Davis, Xiao-Jie Yan, Karla Plevova, Myriam Boudjoghra, Alba Navarro, Davide Rossi, Lone Bredo Pedersen, Vasilis Bikos, Panagiotis Baliakas, Lydia Scarfò, Mattias Mattsson, Aliki Xochelli, Paola Francia di Celle, Krzysztof Giannopoulos, Katrina Vanura, Ludo Evers, Silvio Veronese, Monica Facco, Panagiotis Moschonas, Vojtech Bystry, Teodora Karan-Djurasevic, Maria Roumelioti, Sonja Pavlovic, Larry Mansouri, Charles Chu, Evangelia Stalika, Veronique Giudicelli, Panagiotis Panagiotidis, Andrey Sudarikov, Achilles Anagnostopoulos, Livio Trentin, Mark Catherwood, Marco Montillo, Niki Stavroyianni, Gianluca Gaidano, Elias Campo, Carsten Utoft Niemann, Anton W. Langerak, Sarka Pospisilova, Marie-Paule Lefranc, Ulrich Jaeger, Arnon Kater, Christiane Pott, Nicholas Chiorazzi, David Oscier, Diane F. Jelinek, Stephan Stilgenbauer, Michael Hallek, Dimitrios Tzovaras, Nikos Darzentas, Chrysoula Belessi, Frederic Davi, Richard Rosenquist, Paolo Ghia, Kostas Stamatopoulos
  • Allogeneic Stem Cell Transplantation Versus B-Cell-Receptor Inhibitors in 17p Deletion and/or Refractory Chronic Lymphocytic Leukemia: A Retrospective Comparative Analysis of 'Real Life' Approaches to High Risk Patients, on Behalf of Rete Ematologica Lombarda (REL) and Gruppo Italiano Trapianto Di Midollo Osseo (GITMO)
    Lucia Farina, Francesca Patriarca, Maddalena Mazzucchelli, Chiara Salvetti, Giulia Quaresmini, Marta Medeot, Daniele Vincenti, Gianluigi Reda, Andrea Ferrario, Francesco Zallio, Anna Dodero, Benedetto Bruno, Paolo Corradini, Marco Montillo
  • Personalized Modeling of Disease Evolution in CLL: Does Statistical Significance Translate into Predictive Accuracy?
    Elisavet Chatzilari, Panagiotis Baliakas, Aliki Xochelli, Anastasios Maronidis, Anna Vardi, Mattias Mattsson, Karin Larsson, Vassiliki Douka, Michail Iskas, George Karavalakis, Apostolia Papalexandri, Carsten Niemann, Marco Montillo, Achilles Anagnostopoulos, David Oscier, Sarka Pospisilova, Frederic Davi, Niki Stavroyianni, Paolo Ghia, Anastasia Hadzidimitriou, Richard Rosenquist, Spiros Nikolopoulos, Kostas Stamatopoulos, Yannis Kompatsiaris
  • Is Idelalisib Cost-Effective for Refractory/Relapsed Chronic Lymphocytic Leukemia? a Decision Analysis in the Second-Line Setting
    Monia Marchetti, Antonio Cuneo, Francesca Romana Mauro, Marco Montillo, Elisa Martelli, Maria Paola Pedone
  • Analysis of Prognostic Factors Predictive of Complete Response (CR) to Ibrutinib in Patients with CLL/SLL
    Susan O'Brien, Samantha Jaglowski, John C. Byrd, Rajat Bannerji, Kristie Blum, Christopher P. Fox, Richard R. Furman, Peter Hillmen, Thomas J. Kipps, Marco Montillo, Jeff Sharman, Sam Suzuki, Danelle James, Alvina D. Chu, Steven Coutre
  • CLL with Mutated IGHV4-34 Antigen Receptors Is Clinically Heterogeneous: Antigen Receptor Stereotypy Makes the Difference
    Aliki Xochelli, Panagiotis Baliakas, Andreas Agathangelidis, Anastasia Hadzidimitriou, Lesley-Ann Sutton, Eva Minga, Eugen Tausch, Xiao J. Yan, Tait D. Shanafelt, Karla Plevova, Myriam Boudjogra, Davide Rossi, Zadie Davis, Alba Navarro, Yorick Sandberg, Fie Juhl Vojdeman, Lydia Scarfo, Niki Stavroyianni, Andrey B. Sudarikov, Silvio Veronese, Tatiana Tzenou, Teodora Karan-Djurasevic, Mark Catherwood, Dirk Kienle, Maria Chatzouli, Monica Facco, Jasmin Bahlo, Lone Bredo Pedersen, Larry Mansouri, Karin E Smedby, Charles C Chu, Véronique Giudicelli, Marie-Paule Lefranc, Panagiotis Panagiotidis, Gunnar Juliusson, Achilles Anagnostopoulos, Darko Antic, Livio Trentin, Marco Montillo, Carsten Niemann, Hartmut Döhner, Anton W. Langerak, Nikos Darzentas, Sarka Pospisilova, Michael Hallek, Elias Campo, Nicholas Chiorazzi, David Oscier, Gianluca Gaidano, Chrysoula Belessi, Diane F. Jelinek, Stephan Stilgenbauer, Frederic Davi, Richard Rosenquist, Paolo Ghia, Kostas Stamatopoulos
  • Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia
    Davide Rossi, Lodovico Terzi-di-Bergamo, Lorenzo De Paoli, Michaela Cerri, Guido Ghilardi, Annalisa Chiarenza, Pietro Bulian, Carlo Visco, Francesca R. Mauro, Fortunato Morabito, Agostino Cortelezzi, Francesco Zaja, Francesco Forconi, Luca Laurenti, Ilaria Del Giudice, Massimo Gentile, Iolanda Vincelli, Marina Motta, Marta Coscia, Gian Matteo Rigolin, Alessandra Tedeschi, Antonino Neri, Roberto Marasca, Omar Perbellini, Carol Moreno, Giovanni Del Poeta, Massimo Massaia, Pier Luigi Zinzani, Marco Montillo, Antonio Cuneo, Valter Gattei, Robin Foà, Gianluca Gaidano
  • Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations
    Panagiotis Baliakas, Andreas Agathangelidis, Anastasia Hadzidimitriou, Lesley-Ann Sutton, Eva Minga, Athina Tsanousa, Lydia Scarfò, Zadie Davis, Xiao-Jie Yan, Tait Shanafelt, Karla Plevova, Yorick Sandberg, Fie Juhl Vojdeman, Myriam Boudjogra, Tatiana Tzenou, Maria Chatzouli, Charles C. Chu, Silvio Veronese, Anne Gardiner, Larry Mansouri, Karin E. Smedby, Lone Bredo Pedersen, Denis Moreno, Kirsten Van Lom, Véronique Giudicelli, Hana Skuhrova Francova, Florence Nguyen-Khac, Panagiotis Panagiotidis, Gunnar Juliusson, Lefteris Angelis, Achilles Anagnostopoulos, Marie-Paule Lefranc, Monica Facco, Livio Trentin, Mark Catherwood, Marco Montillo, Christian H. Geisler, Anton W. Langerak, Sarka Pospisilova, Nicholas Chiorazzi, David Oscier, Diane F. Jelinek, Nikos Darzentas, Chrysoula Belessi, Frederic Davi, Paolo Ghia, Richard Rosenquist, Kostas Stamatopoulos

Pages